Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)

SHE:300957 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,250	1,810	2,091	2,514	2,035	751.95
Short-Term Investments	-	-	310	480.12	1,530	-
Trading Asset Securities	2,325	2,428	1,238	1,434	781.15	-
Cash & Short-Term Investments	3,575	4,239	3,640	4,428	4,346	751.95
Cash Growth	21.01%	16.45%	-17.80%	1.89%	477.93%	42.62%
Accounts Receivable	624.95	1,047	742.92	508.76	328.3	326.48
Other Receivables	140.22	173.14	157.87	20.47	37.81	19.33
Receivables	765.17	1,220	900.79	529.23	366.11	345.81
Inventory	556.46	611.89	904.41	670.75	463.27	253.75
Prepaid Expenses	-	6.95	6.98	-	2.92	5.25
Other Current Assets	220.7	55.31	70.57	87.01	46.95	34.41
Total Current Assets	5,117	6,133	5,523	5,715	5,225	1,391
Property, Plant & Equipment	936.31	936.82	808.14	665.36	431.96	109.29
Long-Term Investments	306.36	375.95	298.46	82.78	-	-
Goodwill	323.05	323.05	413.74	-	-	-
Other Intangible Assets	269.55	258.52	193.11	77.94	64.59	55.16
Long-Term Deferred Tax Assets	139.38	129.34	93.13	52.12	15.58	13.35
Long-Term Deferred Charges	102.23	113.59	93.32	66.73	41.02	20.36
Other Long-Term Assets	426.23	33.38	84.45	59.63	34.31	12.53
Total Assets	7,620	8,304	7,507	6,720	5,812	1,602
Accounts Payable	251.44	447.18	401.93	372.37	361.61	134.84
Accrued Expenses	72.83	457.76	469.93	312.06	285.73	150.21
Short-Term Debt	160.8	314.56	103.82	-	-	-
Current Portion of Leases	60.65	63.33	42.1	62.42	48.91	-
Current Income Taxes Payable	29.61	70	105.22	109.69	97.54	65.78
Current Unearned Revenue	57.04	98.97	50.05	58.12	71.19	36.5
Other Current Liabilities	195.7	66.13	118.16	77.21	34.78	3.86
Total Current Liabilities	828.08	1,518	1,291	991.87	899.75	391.19
Long-Term Debt	321.94	321.66	4.7	-	-	-
Long-Term Leases	107.89	118.23	63.28	50.95	76.29	-
Long-Term Unearned Revenue	104.15	112.37	82.86	55.57	6.3	7.41
Long-Term Deferred Tax Liabilities	32.12	33.3	40.45	8.36	1.69	-
Other Long-Term Liabilities	7.41	12.25	8.6	10.5	50	1.45
Total Liabilities	1,402	2,116	1,491	1,117	1,034	400.05
Common Stock	423.6	423.6	423.6	423.6	423.6	360
Additional Paid-In Capital	2,821	2,817	2,846	2,846	2,846	25.71
Retained Earnings	2,980	2,952	2,701	2,283	1,486	813.3
Treasury Stock	-144.96	-144.96	-109.84	-	-	-
Comprehensive Income & Other	-2.32	2.05	0.05	-0	0	-
Total Common Equity	6,078	6,050	5,861	5,553	4,755	1,199
Minority Interest	141.19	137.92	154.82	49.48	23.26	2.81
Shareholders' Equity	6,219	6,188	6,016	5,602	4,778	1,202
Total Liabilities & Equity	7,620	8,304	7,507	6,720	5,812	1,602
Total Debt	651.28	817.77	213.9	113.36	125.2	-
Net Cash (Debt)	2,924	3,421	3,426	4,315	4,221	751.95
Net Cash Growth	10.45%	-0.14%	-20.60%	2.23%	461.28%	46.79%
Net Cash Per Share	7.04	8.16	8.10	10.18	10.37	2.09
Filing Date Shares Outstanding	404.86	421.29	420.61	423.6	423.6	423.6
Total Common Shares Outstanding	404.86	421.29	420.61	423.6	423.6	360
Working Capital	4,289	4,615	4,231	4,723	4,325	999.98
Book Value Per Share	15.01	14.36	13.93	13.11	11.23	3.33
Tangible Book Value	5,485	5,468	5,254	5,475	4,691	1,144
Tangible Book Value Per Share	13.55	12.98	12.49	12.92	11.07	3.18
Buildings	-	251.48	261.2	50.35	33.8	33.8
Machinery	-	649.81	527.8	228.01	124.7	68.73
Construction In Progress	-	50.76	40.22	349.47	197.29	40.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.